Surveillance approaches among colorectal cancer survivors after curative-intent

Minerva Gastroenterologica e Dietologica

Volumn 55, Issue 4, 2009, Pages 483-500

  Haggstrom, D A ^a,b,c,d   Imperiale, T F ^a,b,c,d  

^a RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colon neoplasms; Guidelines; Neoplasm recurrence, local, prevention and control; Rectum neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; BARIUM ENEMA; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SURVEILLANCE; ECHOGRAPHY; FOLLOW UP; HEALTH CARE COST; HUMAN; OCCULT BLOOD TEST; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; THORAX RADIOGRAPHY;

AGE FACTORS; ANTIGENS; CARCINOEMBRYONIC ANTIGEN; COLONOSCOPY; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVORS; TIME FACTORS;

EID: 77949503098     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. American Cancer Society. Colorectal Cancer Facts and Figures Special Edition 2005. Atlanta, GA: ACS; 2005.
2. Ferlay JB, Pisani F, Parkin P. D. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worlwide. In: CancerBase I, ed. Lyon: IARC Press; 2004.
3. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
4. Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol 2003;30:349-60.
5. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 1994;81:7-19.
6. Merkel S, Wein A, Gunther K, Papadopoulos T, Hohenberger W, Hermanek P. High-risk groups of patients with Stage II colon carcinoma. Cancer 2001;92:1435-43.
7. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests. Int J Colorectal Dis 1997;12:329-34.
8. Galandiuk S, Wieand HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992;174:27-32.
9. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 200724:CD002200.
10. Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003;3:26.
11. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. Bmj 2002;324:813.
12. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14.
13. Wattchow DA, Weiler DP, Esterman A, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006;94:1116-21.
14. Rodriguez-Moranta F, Salo J, Arcusa A. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24:386-93.
15. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84:666-9.
16. Barillari P, Ramacciato G, Manetti G, Bovino A, Sammartino P, Stipa V Surveillance of colorectal cancer: effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum 1996;39:388-93.
17. Lennon T HJ, Northover J. What is the value of clinical follow-up for colorectal cancer patients? The experience of the CRC/NIH CEA second-look trial. In: Nottingham International Colorectal Cancer Symposium; 1995;1995.
18. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992;45:255-65.
19. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995;130:1062-7.
20. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995;38:619-26.
21. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998;41:1127-33.
22. Secco GB, Fardelli R, Gianquinto D. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28:418-23.
23. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002;94:167-73.
24. Stiggelbout AM, de Haes JC, Vree R. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997;75:914-20.
25. Pignone MP RM, Teutsch SM, Berg AO, Lohr KN. Screening for Colorectal Cancer in Adults. In: Systematic Evidence Review No 7. Rockville: Agency for Healthcare Research and Quality; 2002.
26. Levin TR, Zhao W, Conell C. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 2006;145:880-6.
27. Desch CE, Benson AB, 3rd, Somerfield MR. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23:8512-9.
28. Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996;83:375-9.
29. Siperstein AE, Berber E, Ballem N, Parikh RT. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007;246:559-65; discussion 65-7.
30. Grothey A, Sugrue MM, Purdie DM. Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE). J Clin Oncol 2008;26:5326-34.
31. Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004;22:1209-14.
32. Desch CE, Benson AB, 3rd, Smith TJ. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol 1999:17:1312.
33. Benson AB, 3rd, Desch CE, Flynn PJ. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000;18:3586-8.
34. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Colon Cancer. 2009. (Accessed July 22, 2009, at http://www.nccn.org/professionals/physician-gls/PDF/colon.pdf.)
35. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Rectal Cancer. 2009. (Accessed July 22, 2009, at http://www.nccn.org/professionals/physician-gls/PDF/rectal.pdf.)
36. Anthony T, Simmang C, Hyman N. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004;47:807-17.
37. Rex DK, Kahi CJ, Levin B. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006;130:1865-71.
38. Van Cutsem E, Oliveira J. Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol 2009;20 Suppl 4:49-50.
39. Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20 Suppl 4:54-6.
40. Chau I, Allen MJ, Cunningham D. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 2004;22:1420-9.
41. Winawer S, Fletcher R, Rex D. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003;124:544-60.
42. Barrier A, Houry S, Huguier M. The appropriate use of colonoscopy in the curative management of colorectal cancer. Int J Colorectal Dis 1998;13:93-8.
43. Carlsson G, Petrelli NJ, Nava H, Herrera L, Mittelman A. The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps. Arch Surg 1987;122:1261-3.
44. Chen F, Stuart M. Colonoscopic follow-up of colorectal carcinoma. Dis Colon Rectum 1994;37:568-72.
45. Eckardt VF, Stamm H, Kanzler G, Bernhard G. Improved survival after colorectal cancer in patients complying with a postoperative endoscopic surveillance program. Endoscopy 1994;26:523-7.
46. Granqvist S, Karlsson T. Postoperative follow-up of patients with colorectal carcinoma by colonoscopy. Eur J Surg 1992;158:307-12.
47. Green RJ, Meday JP, Propert K. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med 2002;136:261-9.
48. Juhl G, Larson GM, Mullins R, Bond S, Polk HC, Jr. Six-year results of annual colonoscopy after resection of colorectal cancer. World J Surg 1990;14:255-60; discussion 60-1.
49. Khoury DA, Opelka FG, Beck DE, Hicks TC, Timmcke AE, Gathright JB, Jr. Colon surveillance after colorectal cancer surgery. Dis Colon Rectum 1996;39:252-6.
50. Kronborg O, Hage E, Deichgraeber E. The remaining colon after radical surgery for colorectal cancer. The first three years of a prospective study. Dis Colon Rectum 1983;26:172-6.
51. McFarland RJ, Becciolini C, Lallemand RC. The value of colonoscopic surveillance following a diagnosis of colorectal cancer or adenomatous polyp. Eur J Surg Oncol 1991;17:514-8.
52. Skaife P, Seow-Choen F, Eu KW, Tang CL. A novel indicator for surveillance colonoscopy following colorectal cancer resection. Colorectal Dis 2003;5:45-8.
53. Stigliano V, Fracasso P, Grassi A. Endoscopic follow-up in resected colorectal cancer patients. J Exp Clin Cancer Res 2000;19:145-8.
54. Togashi K, Konishi F, Ozawa A. Predictive factors for detecting colorectal carcinomas in surveillance colonoscopy after colorectal cancer surgery. Dis Colon Rectum 2000;43:S47-53.
55. Weber CA, Deveney KE, Pellegrini CA, Way LW. Routine colonoscopy in the management of colorectal carcinoma. Am J Surg 1986;152:87-92.
56. Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 1997;40:15-24.
57. Patchett SE, Mulcahy HE, O'Donoghue DP. Colonoscopic surveillance after curative resection for colorectal cancer. Br J Surg 1993;80:1330-2.
58. Dong SM, Traverso G, Johnson C. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001;93:858-65.
59. Traverso G, Shuber A, Levin B. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002;346:311-20.
60. Traverso G, Shuber A, Olsson L. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet 2002;359:403-4.
61. Calistri D, Rengucci C, Bocchini R, Saragoni L, Zoli W, Amadori D. Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol 2003;1:377-83.
62. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
63. Johnson CD, Chen MH, Toledano AY. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17.
64. Regge D, Laudi C, Galatola G. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. Jama 2009;301:2453-61.
65. Gluecker TM, Johnson CD, Wilson LA. Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology 2003;124:911-6.
66. Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings at CT colonography. Radiology 2000;215:353-7.
67. Hellstrom M, Svensson MH, Lasson A. Extracolonic and incidental findings on CT colonography (virtual colonoscopy). AJR Am J Roentgenol 2004;182:631-8.
68. Rajapaksa RC, Macari M, Bini EJ. Prevalence and impact of extracolonic findings in patients undergoing CT colonography. J Clin Gastroenterol 2004;38:767-71.
69. Xiong T, Richardson M, Woodroffe R, Halligan S, Morton D, Lilford RJ. Incidental lesions found on CT colonography: their nature and frequency. Br J Radiol 2005;78:22-9.
70. Yee J, Kumar NN, Godara S. Extracolonic abnormalities discovered incidentally at CT colonography in a male population. Radiology 2005;236:519-26.
71. Cotton PB, Durkalski VL, Pineau BC. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. Jama 2004;291:1713-9.
72. COLOFOL (Evaluation of the Frequency of a Surveillance Program). (Accessed July 22, 2009, at http://www.colofol.com/.)
73. Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? Jama 1999;281:446-53.